1920-780px Inner Pages Header (3)

India possesses the capacity to serve as the global centre for innovations focussed on curable diseases like Tuberculosis and the current technological advancements that exist are inadequate to bridge gaps in neglected diseases that affect the Indian population. It is therefore important to nurture the innovation ecosystem in India and increase investment in the same. It is imperative to integrate cutting-edge technology and systems in all aspects of healthcare facilities on Tuberculosis, particularly surveillance and monitoring mechanisms, diagnostic technologies, treatment approaches, preventive and palliative strategies, and the systems required to make these facilities available and accessible to all those in need. The National Strategic Plan 2017-2025 for tuberculosis elimination by the Government endorses innovations and technologies through collaborative efforts by Government bodies and organizations, including civil society organizations and the private sector players. Innovations that combine affordability along with ground-breaking technology should be encouraged and supported to the very last mile. Elimination of tuberculosis from India will be achieved by breaking the silos, forging partnerships, creating novel business models, and extending support to innovations curated by young entrepreneurs. The platform serves as a comprehensive and collaborative avenue for innovators to showcase their innovations on TB to other corporates, establish linkages with corporates, and explore investment/funding avenues for their innovations.

The Corporate TB Pledge (CTP) program is a joint initiative of the Central TB Division, Ministry of Health and Family Welfare, Government of India and USAID in collaboration with The International Union Against Tuberculosis and Lung Diseases, with the objective to develop a shared TB vision, in alignment with PM Narendra Modi’s vision of eliminating TB in India by 2025. The Corporate TB Pledge program was launched in April 2019 and offers a tiered approach for corporates to use their resources (human and financial), to combat TB, raise awareness of TB as a curable disease, and ultimately improve TB health outcomes.